Mitsuko Onda
Osaka University of Pharmaceutical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mitsuko Onda.
BMJ Open | 2015
Mitsuko Onda; Hirohisa Imai; Yurina Takada; Shingo Fujii; Takako Shono
Objectives A nationwide large-scale survey was conducted to identify the prevalence and causal medications of adverse drug events (ADEs) that are caused by potentially inappropriate medications (PIMs) given to homebound elderly patients, factors associated with ADEs, and measures taken by pharmacists to manage ADEs and their effects on ADEs. Settings A questionnaire was mailed to 3321 pharmacies nationwide. It asked about the details of PIMs and ADEs of up to 5 patients for whom home visits were provided by a pharmacist. Questionnaire forms were filled in by pharmacists who visited the patients. Design and participants Between 23 January and 13 February 2013, comprehensive assessment forms were sent to 3321 pharmacies. Data collected from 1890 pharmacies including data of 4815 patients were analysed and 28 patients of unknown sex were excluded. Their average age was 82.7u2005years. PIMs were identified based on the 2003 Beers Criteria Japan. Results There were 600 patients who did not provide valid answers regarding the medications. In the remaining 4243 patients, one or more medications that were considered to be PIMs had been prescribed to 48.4% of patients. PIM-induced ADEs were found in 8% of these patients by pharmacists during home visits. The top ADE-inducing medications were strong anticholinergic antihistamines, benzodiazepines, sulpiride and digoxin. The most common ADEs associated with benzodiazepines were frequent lightheadedness, somnolence and sleepiness, which increase the risk of falls and subsequent fractures in elderly patients. The following factors associated with ADEs were identified: sex, pharmacist awareness of prescription issues, frequency of visits and time spent at patients’ homes, and the frequency of detailed checks for patient adverse reactions by pharmacists. Conclusions The PIM prevalence associated with home healthcare in Japan was relatively high, as reported in previous studies. The present study suggests that pharmacists could reduce the incidence of PIMs and consequent ADEs.
Japanese Journal of Social Pharmacy | 2013
Mitsuko Onda; Hirohisa Imai; Yuta Kataoka; Makoto Takamatsu; Masako Tanaka; Hidekazu Tanaka; Yukio Arakawa
Aim : To examine any relations of workload and outcomes of pharmacistsʼ home visiting service for medication management and guidance. Survey Target : Managing pharmacists and home-visiting pharmacists from community pharmacies of the Osaka Pharmaceutical Associationʼs Yao and Toyonaka branches as of March, 2012. Methods : Survey forms regarding drug management and guidance at patientsʼ homes were mailed, requesting mail or online response. Workload indexes were visit frequency and work time on site. The relation of workload and its outcomes was examined using univariate analysis regarding three items : change in unused medication amount ; detection of side effects during visits ; change in prescription. SPSS ver. 20 for Windows was used for statistical analysis. Results : 90 of 201 pharmacies responded (collection rate 44.8%), and 110 home patientsʼ data were analyzed. 5-to-15-minute actual work time scored highest (57.4%), followed by less than 5 minutes and 15 to 30 minutes, both at 21.3%. Visit frequency of twice a month scored highest (70.4%), followed by once a week (19.4%), once a month (7.4%), and once in more than one month (2.8%). 5-minute or longer patient visits had a tendency of higher percentage of patients whose unused medication decreased after visits started than less-than-5-minute visits (P=0.072). “Once a week” visits had a tendency of higher percentage of pharmacists detecting side effects than less frequent visits (P=0.061) and changing in prescription (P=0.085). Conclusion : The results above implied the relationship between workload and outcomes incurred by pharmacistsʼ home visits for medication safety management and guidance.
BioScience Trends | 2017
Hiroshi Okada; Mitsuko Onda; Masaki Shoji; Naoki Sakane; Yasushi Nakagawa; Takashi Sozu; Yui Kitajima; Ross T. Tsuyuki; Takeo Nakayama
The COMmunity Pharamcists ASSist for Blood Pressure (COMPASS-BP) study aimed to assess the effectiveness of lifestyle support programs administered in community pharmacies on hypertension control. This open-label, two-armed parallel group, cluster-randomized controlled trial included 73 pharmacies (clusters) in Japan randomized to a control or intervention group. Eligible hypertensive patients (n = 125), aged 20-75 years, received the intervention (n = 64) or the control treatment (n = 61), as dictated by their pharmacy randomization. Patients in the intervention group received brochures and healthy lifestyle advice from pharmacists using motivational interviewing methods during pharmacy visits over a 12-week period, with their usual pharmacy care. Conversely, the control group just received usual care. The main outcome measure was a change in morning systolic blood pressure (SBP) from baseline to week 12. The intervention group exhibited a decrease in morning SBP that was 6.0 mmHg greater than that of the control group (95% confidence interval [CI]: -11.0 to -0.9, p = 0.021). In a mixed-effect model for repeated measures analysis, the intergroup difference in morning SBP decrease was -4.5 mmHg (95% CI: -8.5 to -0.6, p = 0.024). Our findings indicate that implementation of a lifestyle advice program in pharmacies is feasible and may lead to reduced blood pressure.
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2015
Mitsuko Onda; Kenichi Tsubota; Rie Tanaka; Yusuke Mukai; Syunya Matoba; Yuka Tanaka; Yukio Arakawa
In Japan the prevalence of dementia has increased considerably, and pharmacists are involved in addressing these patients medication-related problems. Here, we determined whether pharmacists comprehensive assessment of medication profiles could reduce the burden of dementia patients medication-related problems. In this historical cohort study 120 community pharmacies were randomly selected, and participating pharmacists completed questionnaires concerning comprehensive assessment of patient medication profiles, using a start questionnaire for patients prescribed medication prior to or during the study period and a follow-up questionnaire for patients who subsequently visited pharmacies for prescriptions. Numbers and details of problems and solutions implemented by pharmacists and identified in the start and follow-up questionnaires were compared. Changes in start and follow-up scores were also compared between patients whose problems were identified by pharmacists (identified group) and those whose problems were not (non-identified group). Data were collected for 349 patients issued medication by 60 pharmacies. The most common medication-related problems identified in the start survey were key persons understanding of donepezil (60 cases) and other dementia treatments (60 cases), and adherence to treatment (53 cases). Solutions implemented by pharmacists included gathering information regarding drug administration and dementia awareness from the key person and providing pharmaceutical counseling and instruction. Subsequently, problems related to understanding of dementia treatment, understanding donepezil, and adherence were resolved by 70.0%, 65.0%, and 58.5%, respectively. Pharmacists comprehensive assessment of medication profiles could effectively solve dementia patients medication-related problems.
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2018
Naohito Maeta; Masaki Shoji; Moe Hashimoto; Yukio Arakawa; Mitsuko Onda
u3000The objective of this survey is investigating pharmacists recognition of and belief in the importance of doing PRE-AVOID using the drug profile book (DPB). The main survey items were: 1. Awareness and self-confidence concerning PRE-AVOID using DPB, 2.Status of educating patients of the merits of the DPB, 3. Status of educating patients of the utilities of the DPB, 4. Status of educating patients of the roles of the DPB, 5. Guidance provided on methods of DPB usage, and 6. Interactions with patients. A multiple regression analysis was performed using Awareness and self-confidence concerning PRE-AVOID using DPB as a dependent variable. A regression equation including three items (Educating the roles, Blood test, and Not using multiple DPBs at same time) was derived for Self-confidence in PRE-AVOID work (R2=0.20). The item most affecting Self-confidence in PRE-AVOID work was Educating the roles (R=0.28). A regression equation with Awareness of PRE-AVOID work as a dependent variable was not derived. The results of the study suggest that Educating the roles or Not using multiple DPBs at same time for patients, and asking the results of Blood test in a medication consultation may increase pharmacists belief in doing PRE-AVOID.
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2018
Ryota Hashimoto; Keiko Fujii; Kazuko Yoshida; Shizuka Shimoji; Hidenori Masaki; Kaori Kadoyama; Toshiaki Nakamura; Mitsuko Onda
u3000The current study aimed to examine the outcomes of pharmacists involvement with elderly people in special nursing homes. We analyzed 58 cases involving regular visits by community pharmacists to 41 residents. The residents mean age was 87.8±6.9 years, and 68.3% were prescribed 6 or more types of medication. Antipsychotic and insomnia medication was taken by 24.4% and 31.8% of residents, respectively. Pharmaceutical consultation following medication use accounted for 60.3% of pharmacists involvement with residents. The outcomes of these consultations included improvements in prescription content; the identification and prevention of adverse drug events; improvement in activities of daily living; and improvement in test results, sleep, and urination/bowel control. The results also suggested that pharmacists intervention reduced drug costs. Information that facilitated involvement was most frequently acquired via conversations (67.2%) and conferences (24.1%) in the facilities. The most common information sources were care workers (72.4%), followed by nurses (37.9%), physicians (6.9%), and functional training instructors (6.9%). Information was also acquired from patients (3.4%) and their family members (5.2%). The findings indicated that regular visits by pharmacists to facilities for elderly people and conversations between residents, their family members, and physicians, nurses and various other professionals improved various pharmacotherapy outcomes.
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2018
Mitsuko Onda; Nobumasa Takagaki
u3000Osaka University of Pharmaceutical Sciences has included an evidence-based medicine (EBM) exercise in the introductory education for clinical practice for 4th-year pharmacy students since 2015. The purpose of this exercise is to learn the process of practice and basic concepts of EBM, especially to cultivate the practical ability to solve patients problems and answer their questions. Additionally, in 2016, we have attempted flipped teaching. The students are instructed to review the basic knowledge necessary for active learning in this exercise by watching video teaching materials and to bring reports summarizing the contents on the flipped teaching days. The program includes short lectures [overview of EBM, document retrieval, randomized controlled trials (RCTs), and systematic review], exercises [patient, intervention, comparison, outcome (PICO) structuring, critical appraisal of papers in small groups with tutors], and presentations. The program includes: step 1, PICO structuring based on scenarios; step 2, critical appraisal of English-language papers on RCTs using evaluation worksheets; and step 3, reviewing the results of the PICO exercise with patients. The results of the review are shared among groups through general discussion. In this symposium, I discuss students attitudes, the effectiveness of small group discussions using flipped teaching, and future challenges to be addressed in this program.
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2009
Mitsuko Onda; Hidehiko Sakurai; Yukitoshi Hayase; Hiroyuki Sakamaki; Yukio Arakawa; Fumiaki Yasukawa
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2007
Yoshihiko Hirotani; Takuya Ikeda; Kenji Ikeda; Kaoru Yamamoto; Mitsuko Onda; Yukio Arakawa; Jun Li; Kazuyuki Kitamura; Nobuo Kurokawa
Biomedical Research-tokyo | 2007
Yukio Arakawa; Noriyasu Hashida; Nobuyuki Ohguro; Noboru Yamazaki; Mitsuko Onda; Syoji Matsumoto; Masako Ohishi; Kaoru Yamabe; Yasuo Tano; Nobuo Kurokawa